Chemical Modification of siRNAs for in vivo Use

Author(s): Behlke MA

Abstract

Well over a hundred reports have been published describing use of synthetic small-interfering RNAs (siRNAs) in animals. The majority of these reports employed unmodified RNA duplexes. While unmodified RNA is the natural effector molecule of RNA interference, certain problems arise with experimental or therapeutic use of RNA duplexes in vivo, some of which can be improved or solved through use of chemical modifications. Judicious use of chemical modifications can improve the nuclease stability of an RNA duplex, decrease the likelihood of triggering an innate immune response, lower the incidence of off-target effects (OTEs), and improve pharmacodynamics. This review will examine studies that document the utility of various chemical modifications for use in siRNAs, both in vitro and in vivo, with close attention given to reports demonstrating actual performance in animal model systems.

Similar Articles

Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis

Author(s): Chin KL, Anis FZ, Sarmiento ME, Norazmi MN, Acosta A, et al.

Role of Type I and II Interferons in Colorectal Cancer and Melanoma

Author(s): Di Franco S, Turdo A, Todaro M, Stassi G

Innate immune response induced by gene delivery vectors

Author(s): Sakurai H, Kawabata K, Sakurai F, Nakagawa S, Mizuguchi H, et al.

Analysis of Pro-inflammatory Cytokine and Type II Interferon Induction by Nanoparticles

Author(s): Potter TM, Neun BW, Rodriguez JC, Ilinskaya AN, Dobrovolskaia MA, et al.

More than 70 years of pyrogen detection: Current state and future perspectives

Author(s): Fennrich S, Hennig U, Toliashvili L, Schlensak C, Wendel HP, et al.

Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test

Author(s): Hasiwa N, Daneshian M, Bruegger P, Fennrich S, Hochadel A, et al.

International validation of novel pyrogen tests based on human monocytoid cells

Author(s): Hoffmann S, Peterbauer A, Schindler S, Fennrich S, Poole S, et al.

Nucleic acids as therapeutic agents

Author(s): Alvarez-Salas LM

Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents

Author(s): Monteith DK, Henry SP, Howard RB, Flournoy S, Levin AA, et al.

Aptamers as therapeutics

Author(s): Keefe AD, Pai S, Ellington A

5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I

Author(s): Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, et al.